Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
about
Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to benchGinseng is useful to enhance cardiac contractility in animals.Merit of ginseng in the treatment of heart failure in type 1-like diabetic rats.Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ-STAT3 Signaling in Type 1-Like Diabetic Rats.
P2860
Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cardiac peroxisome proliferato ...... y without altering heart rate.
@ast
Cardiac peroxisome proliferato ...... y without altering heart rate.
@en
Cardiac peroxisome proliferator-activated receptor δ
@nl
type
label
Cardiac peroxisome proliferato ...... y without altering heart rate.
@ast
Cardiac peroxisome proliferato ...... y without altering heart rate.
@en
Cardiac peroxisome proliferator-activated receptor δ
@nl
prefLabel
Cardiac peroxisome proliferato ...... y without altering heart rate.
@ast
Cardiac peroxisome proliferato ...... y without altering heart rate.
@en
Cardiac peroxisome proliferator-activated receptor δ
@nl
P2093
P2860
P1433
P1476
Cardiac peroxisome proliferato ...... y without altering heart rate.
@en
P2093
Ho-Shan Niu
Juei-Tang Cheng
Kung Shing Lee
Li-Jen Chen
Lin-Yu Wang
Zhih-Cherng Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0064229
P407
P577
2013-05-28T00:00:00Z